Headache in Patients with Celiac Disease and Its Response to the Gluten-Free Diet

Aims: To disease (CD) patients and to analyze the relationship between CD and headache. Methods: An online survey analyzing the characteristics of headache and its response to the gluten- free diet (GFD) in celiac patients was published on Argentinean Celiac social networks, open to the public to complete. The results were analyzed using chi- square test or Mann-Whitney test accordingly. Results: A total of 1,517 subjects completed the survey, and 866 (55.2%) met the inclusion criteria (headache and CD confirmed with positive biopsy). The subjects were predominantly female (94.5%) and had a median age of 39 ± 11.27 years. Tension-type headache was the most prevalent headache type (52%), followed by migraine without (32.5%) and with aura (15.4%), respectively. Of the included participants, 24% reported headache as the main symptom that resulted in the diagnosis of CD. Following initiation of GFD, headache frequency and intensity improved significantly more in participants with migraine than tension-type headache (P = .02 and P = .013, respectively). Compliance to GFD was higher among subjects with severe manifestations (77% vs 66%, P = .05), and compliant individuals showed a 48% improvement in headache frequency (P = .049). An association between food transgressions and headache was better recognized by migraineurs (P = .02). Conclusion: These results suggest that strict compliance to the GFD could improve headache in celiac patients with headache, even in those without gastrointestinal symptoms. This observation could provide an additional factor when convincing patients to follow a GFD, thus reducing the morbidity related to CD.

celiac disease;gluten;gluten-free diet;headache;migraine;migraine with aura

1. Fasano A, Catassi C. Clinical practice. Celiac disease. N Engl J Med 2012;367:2419–2426.

2. Tonutti E, Bizzaro N. Diagnosis and classification of celiac dis- ease and gluten sensitivity. Autoimmun Rev 2014;13:472–476.

3. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: A large multicenter study. Arch Intern Med 2003;163:286–292.

4. Biagi F, Klersy C, Balduzzi D, Corazza GR. Are we not over-estimating the prevalence of celiac disease in the general population? Ann Med 2010;42:557–561.

5. Mora M, Litwin N, Toca Mdel C, et al. Prevalence of celiac disease: Multicentric trial among pediatric population from five urban districts in Argentina. Arch Argent Pediatr 2012; 110:490–496.

6. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009;137:88–93.

7. Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: A cohort study. Lancet 2001;358:356–361.

8. Godfrey JD, Brantner TL, Brinjikji W, et al. Morbidity and mor- tality among older individuals with undiagnosed celiac dis- ease. Gastroenterology 2010;139:763–769.

9. Cooke WT, Smith WT. Neurological disorders associated with adult coeliac disease. Brain 1966;89:683–722.

10. Hadjivassiliou M, Gibson A, Davies-Jones GA, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness? Lancet 1996;347:369–371.

11. Hanagasi HA, Gürol E, Sahin HA, Emre M. Atypical neurolog- ical involvement associated with celiac disease. Eur J Neurol 2001;8:67–69.

12. Chin RL, Latov N. Peripheral neuropathy and celiac disease. Curr Treat Options Neurol 2005;7:43–48.

13. Hadjivassiliou M, Grünewald R, Sharrack B, et al. Gluten atax- ia in perspective: Epidemiology, genetic susceptibility and clin- ical characteristics. Brain 2003;126:685–691.

14. Luostarinen L, Himanen SL, Luostarinen M, Collin P, Pirttilä T. Neuromuscular and sensory disturbances in patients with well treated coeliac disease. J Neurol Neurosurg Psychiatry 2003;74:490–494.

15. Arroyo HA, De Rosa S, Ruggieri V, et al. Epilepsy, occipital calcifications, and oligosymptomatic celiac disease in child- hood. J Child Neurol 2002;17:800–806.

16. Hu WT, Murray JA, Greenaway MC, Parisi JE, Josephs KA. Cognitive impairment and celiac disease. Arch Neurol 2006; 63:1440–1446.

17. Hadjivassiliou M, Chattopadhyay AK, Grünewald RA, et al. Myopathy associated with gluten sensitivity. Muscle Nerve 2007;35:443–450.

18. Dimitrova AK, Ungaro RC, Lebwohl B, et al. Prevalence of mi- graine in patients with celiac disease and inflammatory bowel disease. Headache 2013;53:344–355.

19. Gabrielli M, Cremonini F, Fiore G, et al. Association between migraine and celiac disease: Results from a preliminary case-control and therapeutic study. Am J Gastroenterol 2003; 98:625–629.

20. Benjilali L, Zahlane M, Essaadouni L. A migraine as ini- tial presentation of celiac disease. Rev Neurol (Paris) 2012; 168:454–456.

21. Bürk K, Farecki ML, Lamprecht G, et al. Neurological symp- toms in patients with biopsy proven celiac disease. Mov Disord 2009;24:2358–2362.

22. Lebwohl B, Roy A, Alaedini A, Green PHR, Ludvigsson JF. Risk of headache-related healthcare visits in patients with celiac disease: A population-based observational study. Headache 2016;56:849–858.

23. Petrarca L, Nenna R. Headache and celiac disease: An in- creasingly investigated association. Headache 2016;56: 1520–1521.

24. Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain 2000;88:41–52.

25. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629–808.

26. Green PH, Alaedini A, Sander HW, Brannagan TH 3rd, Latov N, Chin RL. Mechanisms underlying celiac disease and its neu- rologic manifestations. Cell Mol Life Sci 2005;62:791–799.

27. Suárez Llanos JP, González Melo E, Mora Mendoza A, Iacampo Leiva LD, Moro Miguel MA. Celiac disease and mal- absorption: A case report of ataxia secondary to vitamin E de- ficiency. Endocrinol Nutr 2014;61:389–390.

28. Diaconu G, Burlea M, Grigore I, Anton DT, Trandafir LM. Celiac disease with neurologic manifestations in children. Rev Med Chir Soc Med Nat Iasi 2013;117:88–94.

29. Briani C, Zara G, Alaedini A, et al. Neurological complications of celiac disease and autoimmune mechanisms: A prospective study. J Neuroimmunol 2008;195:171–175.

30. Smith WG. Does gender influence online survey participation? A record-linkage analysis of university faculty online survey re-sponse behavior. ERIC Clearinghouse, 2008.